Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PENNISI, Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.084
EU - Europa 463
AS - Asia 292
AF - Africa 10
OC - Oceania 6
SA - Sud America 6
Totale 1.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.080
IT - Italia 303
SG - Singapore 144
CN - Cina 88
DE - Germania 54
HK - Hong Kong 29
GB - Regno Unito 25
IN - India 15
FI - Finlandia 13
RO - Romania 10
IE - Irlanda 9
SE - Svezia 9
BE - Belgio 8
CI - Costa d'Avorio 7
FR - Francia 7
AU - Australia 6
RU - Federazione Russa 6
SA - Arabia Saudita 5
CA - Canada 4
NL - Olanda 4
UA - Ucraina 4
CZ - Repubblica Ceca 3
JP - Giappone 3
KR - Corea 3
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
ES - Italia 2
IR - Iran 2
PE - Perù 2
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
MA - Marocco 1
NO - Norvegia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.861
Salva come PNG Salva come JPEG
Città #
Chandler 170
Fairfield 115
Singapore 115
Ashburn 105
Palermo 66
Ann Arbor 63
Woodbridge 59
Seattle 41
Houston 37
New York 37
Wilmington 37
Cambridge 31
Medford 29
Santa Clara 28
Central 26
Altamura 25
Rome 24
Des Moines 23
Ludwigshafen am Rhein 21
Princeton 21
Lawrence 19
San Diego 18
Beijing 12
Milan 12
Washington 11
Dublin 9
Gallarate 9
Lappeenranta 9
Brussels 8
Columbus 8
London 8
San Paolo di Civitate 8
Abidjan 7
Aragona 6
Boardman 6
Bremen 6
Mussomeli 6
Pune 6
Los Angeles 5
Nanjing 5
Riyadh 5
Barcellona Pozzo di Gotto 4
Como 4
Gothenburg 4
Busto Arsizio 3
Council Bluffs 3
Dallas 3
Gradara 3
Guangzhou 3
Helsinki 3
Kilburn 3
Kumar 3
Nanchang 3
Oakland 3
Olomouc 3
Shenyang 3
Shenzhen 3
Signal Mountain 3
Sydney 3
Tokyo 3
Venice 3
Zhengzhou 3
Bari 2
Bernareggio 2
Bollate 2
Brescia 2
Buonconvento 2
Carini 2
Chennai 2
Cipolletti 2
Dearborn 2
Ficarazzi 2
Frankfurt am Main 2
Genoa 2
Hong Kong 2
Karaikudi 2
Krefeld 2
Messina 2
Misilmeri 2
Misterbianco 2
Modigliana 2
Ottawa 2
Parma 2
Pisa 2
Potenza 2
Ravanusa 2
Salemi 2
Sassari 2
Seongnam 2
Seville 2
Shanghai 2
Southwark 2
Toronto 2
Xi'an 2
Amsterdam 1
Anshan 1
Aversa 1
Aylesbury 1
Bad Durrheim 1
Baltimore 1
Totale 1.392
Salva come PNG Salva come JPEG
Nome #
Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? 167
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 139
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives 117
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives 113
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 100
MAFLD: a multisystem disease 97
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION 94
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION 82
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population 73
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 72
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 59
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease 55
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis 53
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease 50
Biochemical biomarkers of NAFLD/NASH 50
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes 42
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 41
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 41
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease 41
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices 40
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 40
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD 38
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 37
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease 35
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 35
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease 34
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis 34
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD 33
Heart rate variability is associated with disease severity and portal hypertension in cirrhosis 31
Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C 24
The relevance of noninvasive tools to assess fibrosis in non-alcoholic fatty liver disease 23
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD 21
The PD-1/PD-L1 Axis in the Biology of MASLD 21
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity 18
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 16
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease 12
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies 12
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease 12
Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease? 11
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis 11
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] 11
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease 11
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 11
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria 10
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility 10
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease 10
Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD 10
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) 10
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 10
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease 9
Correction to: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women (Nature Medicine, (2023), 29, 10, (2643-2655), 10.1038/s41591-023-02553-8) 9
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 8
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study 8
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 8
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease 7
Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease 7
Totale 2.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 9 39 19 15 25 12 25 1
2020/2021249 8 16 20 35 17 5 25 12 23 29 40 19
2021/2022286 12 26 22 11 6 10 7 48 25 33 36 50
2022/2023594 35 92 4 71 53 68 31 92 70 7 44 27
2023/2024433 18 36 25 33 31 130 44 10 10 28 20 48
2024/2025409 28 54 137 137 53 0 0 0 0 0 0 0
Totale 2.173